AbbVie (ABBV) Finished Goods (2012 - 2016)

AbbVie has disclosed Finished Goods across 5 years of filings, most recently posting $556.0 million for Q2 2016.

• In Q2 2016, Finished Goods rose 16.32% year-over-year to $556.0 million; the TTM figure through Jun 2016 stood at $556.0 million (up 16.32% YoY), while the FY2015 annual figure was $469.0 million, up 37.54% from the prior year.
• Finished Goods climbed to $556.0 million in Q2 2016, from $552.0 million in the prior quarter.
• Over the last five years, Finished Goods for ABBV reached as high as $640.0 million in Q3 2015 and fell as low as $280.0 million in Q3 2014.
• The 5-year median for Finished Goods is $485.0 million (2013), against an average of $479.5 million.
• Annual changes were most pronounced in 2014 — Finished Goods slumped 41.42% — and 2015, when it jumped 128.57%.
• A 5-year view of Finished Goods shows it stood at $547.0 million in 2012, then dropped by 11.33% to $485.0 million in 2013, then decreased by 29.69% to $341.0 million in 2014, then soared by 37.54% to $469.0 million in 2015, then rose by 18.55% to $556.0 million in 2016.
• According to Business Quant data, Finished Goods over the past three periods registered $556.0 million, $552.0 million, and $469.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.